Listen Now! To our Podcast regarding our recent publication in the Journal of the American Heart Association that research findings on the chP3R99 antibody which has the potential to be effective across many stages of atherosclerosis development.

 

---

For more information on our JAHA publication

Yosdel Soto, Arletty Hernández, Roger Sarduy, Victor Brito, Sylvie Marleau, Donna F. Vine, Ana M. Vázquez, Spencer D. Proctor.   Monoclonal Antibody chP3R99 Reduces Subendothelial Retention of Atherogenic Lipoproteins in Insulin‐Resistant Rats: Acute Treatment Versus Long‐Term Protection as an Idiotypic Vaccine for Atherosclerosis. Journal of the American Heart Association.  27 June 2024, Volume 13, Number 13.  https://doi.org/10.1161/JAHA.123.032419